| November 2012 | The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files
w18552
|
| July 2012 | Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009
w18235
|
| January 2012 | The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey
w17750
|
| September 2011 | The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007
w17414
|
| August 2010 | Are the More Educated More LIkely to Use New Drugs?
with Adriana Lleras-Muney, Frank R. Lichtenberg
in Contributions in Memory of Zvi Griliches, Jacques Mairesse and Manuel Trajtenberg, editors
|
| June 2010 | Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia
w16051
|
| April 2010 | Has medical innovation reduced cancer mortality?
w15880
|
| June 2009 | The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth
w15068
|
| May 2008 | Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003
w14008
|
| Pharmaceutical innovation and the longevity of Australians: a first look
with Frank R. Lichtenberg, Gautier Duflos: w14009
|
| December 2007 | Pharmaceutical Innovation and U.S. Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data
in Frontiers in Health Policy Research, Volume 10, David Cutler, Alan Garber, and Dana Goldman, organizers
|
| September 2006 | Importation and Innovation
w12539
|
| August 2006 | The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data
w12406
|
| March 2006 | The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data
w12120
|
| August 2005 | Pharmaceutical Knowledge-Capital Accumulation and Longevity
in Measuring Capital in the New Economy, Carol Corrado, John Haltiwanger and Dan Sichel, editors
|
| November 2004 | The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program
w10884
|
| February 2004 | The Expanding Pharmaceutical Arsenal in the War on Cancer
w10328
|
| June 2003 | Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act
with Frank R. Lichtenberg, Joel Waldfogel: w9750
|
| The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001
w9754
|
| November 2002 | Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health"
with Frank R. Lichtenberg, Suchin Virabhak: w9351
|
| The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry
with Frank R. Lichtenberg, Tomas J. Philipson: w9303
|
| September 2002 | The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output
w9139
|
| The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs
with Adriana Lleras-Muney, Frank R. Lichtenberg: w9185
|
| June 2002 | Benefits and Costs of Newer Drugs: An Update
w8996
|
| January 2002 | Sources of U.S. Longevity Increase, 1960-1997
w8755
|
| The Effects of Medicare on Health Care Utilization and Outcomes
in Frontiers in Health Policy Research, Volume 5, Alan M. Garber, editor
|
| December 2001 | The Effect of New Drugs on Mortality from Rare Diseases and HIV
w8677
|
| March 2001 | The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
w8147
|
| January 2001 | The Allocation of Publicly Funded Biomedical Research
in Medical Care Output and Productivity, David M. Cutler and Ernst R. Berndt, editors
|
| June 1998 | The Allocation of Publicly-Funded Biomedical Research
w6601
|
| May 1998 | Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
w6569
|
| May 1997 | The Impact and Organization of Publicly-Funded Research and Development in the European Community
with Maryann P. Feldman, Frank R. Lichtenberg: w6040
|
| July 1996 | International R&D Spillovers: A Re-Examination
with Frank Lichtenberg, Bruno van Pottelsberghe de la Potterie: w5668
|
| June 1996 | The Effect of New Political Administration on Federal Government Productivity and Employment
w5601
|
| Computer Use and Productivity Growth in Federal Government Agencies, 1987 to 1992
with William Lehr, Frank R. Lichtenberg: w5616
|
| April 1996 | Labor Market Institutions, Liquidity Constraints, and Macroeconomic Stability
w3926
|
| The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis
w4540
|
| January 1996 | The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality
w5418
|
| March 1995 | Ownership Structure and Corporate Performance in Japan
with Frank R. Lichtenberg, George. M Pushner: w4092
|
| September 1993 | R&D Investment and International Productivity Differences
w4161
|
| October 1991 | The Impact of R&D Investment On Productivity - New Evidence Using Linked R&D-LRD Data
with Frank R. Lichtenberg, Donald Siegel: w2901
|
| September 1991 | Technical Change, Learning, and Wages
with Ann P. Bartel, Frank R. Lichtenberg: w2732
|
| The Effects of Leveraged Buyouts on Productivity and Related Aspects of Firm Behavior
with Frank R. Lichtenberg, Donald Siegel: w3022
|
| March 1991 | The Effect of Takeovers on the Employment and Wages of Central-Office and Other Personnel
with Frank Lichtenberg, Donald Siegel: w2895
|
| June 1990 | Government Subsidies to Private Military R&D Investment: DOD's IR&D Policy
w2745
|
| April 1990 | How Elastic is the Government's Demand for Weapons?
w3025
|
| January 1990 | Industrial De-Diversification and its Consequences for Productivity
w3231
|
| December 1989 | The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84
with Frank R. Lichtenberg, Moshe Kim: w3197
|
| July 1989 | IR&D Project Data and Theories of R&D Investment
w2720
|
| June 1989 | Productivity and Changes in Ownership of Manufacturing Plants
with Frank R. Lichtenberg, Donald Siegel: r1208
|
| April 1989 | Errors of Measurement in Output Deflators
with Frank R. Lichtenberg, Zvi Griliches: w2000
|
| February 1989 | Private Investment in R&D to Signal Ability to Perform Government Contracts
w1974
|
| October 1985 | The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence
with Ann P. Bartel, Frank R. Lichtenberg: w1718
|
| November 1984 | Interindustry Technology Flows and Productivity Growth: A Reexamination
with Zvi Griliches, Frank R. Lichtenberg: r0542
|
| 1984 | R&D and Productivity Growth at the Industry Level: Is There Still a Relationship?
with Zvi Griliches, Frank R. Lichtenberg
in R & D, Patents, and Productivity, Zvi Griliches, ed.
|
| February 1982 | R and D and Productivity at the Industry Level: Is There Still a Relationship?
with Zvi Griliches, Frank R. Lichtenberg: w0850
|
| May 1981 | Training, Tenure, and Productivity
w0671
|
